Israelis Invent Oral COVID Vaccine

Another gift from the Jews. Perhaps “Palestinians” could take a page – their main export (only export) is genocide and Jew-hatred. Time to be life-affirming and productive, not evil.

Quick note: Tech giants are shutting us down. You know this. Twitter, LinkedIn, Google Adsense, Pinterest permanently banned us. Facebook, Google search et al have shadow-banned, suspended and deleted us from your news feeds. They are disappearing us. But we are here. We will not waver. We will not tire. We will not falter, and we will not fail. Freedom will prevail.

Subscribe to Geller Report newsletter here — it’s free and it’s critical NOW when informed decision making and opinion is essential to America's survival. Share our posts on your social channels and with your email contacts. Fight the great fight.

Remember, YOU make the work possible. If you can, please contribute to Geller Report.

Israelis Invent Oral COVID Vaccine

Encouraged by clinical trials, Israeli startup hopes to make oral Covid booster commercially available within a year.

By United With Israel, June 13, 2021:

An Israeli startup company developing a booster COVID vaccine for people who have already been vaccinated announced that preclinical tests on laboratory rats yielded promising results.

The vaccine is administered orally.

In a statement, the Qiryat Shemona-based Migvax said its vaccine resulted in “markedly higher neutralizing antibod[ies]” and “elicited more effective neutralizing antibodies.”
The Migvax formulation may also “remain effective for longer periods of time before requiring a booster” and does not require deep freeze storage, making it easier to transport. The company said the vaccine would still require regular refrigeration.

Administering the booster orally will also benefit other countries struggling to keep the pandemic under control.

“Oral boosters such as our MigVax-101 will be key enablers that will help health organizations the world over transition from ‘panic mode’ to routine, due to their ability to reduce the cost and expand the reach of ongoing vaccination programs,” the statement said.

Migvax’s statement said it was seeking finances to launch the next phase of clinical trials, aiming for commercial availability within 9-12 months.

Encouraged by clinical trials, Israeli startup hopes to make its oral Covid booster commercially available within a year. The startup is an affiliate of the Migal Galilee Research Institute.

Have a tip we should know? Your anonymity is NEVER compromised. Email tips@thegellerreport.com

The Truth Must be Told

Your contribution supports independent journalism

Please take a moment to consider this. Now, more than ever, people are reading Geller Report for news they won't get anywhere else. But advertising revenues have all but disappeared. Google Adsense is the online advertising monopoly and they have banned us. Social media giants like Facebook and Twitter have blocked and shadow-banned our accounts. But we won't put up a paywall. Because never has the free world needed independent journalism more.

Everyone who reads our reporting knows the Geller Report covers the news the media won't. We cannot do our ground-breaking report without your support. We must continue to report on the global jihad and the left's war on freedom. Our readers’ contributions make that possible.

Geller Report's independent, investigative journalism takes a lot of time, money and hard work to produce. But we do it because we believe our work is critical in the fight for freedom and because it is your fight, too.

Please contribute here.


Make a monthly commitment to support The Geller Report – choose the option that suits you best.

Pin It on Pinterest